Clinical Trials on Venous Occlusion in Czechia

Total 201 results

University Hospital, Motol

Unknown

Upper Limb Thrombosis Associated With Midline Catheter

Venous Thrombosis Deep (Limbs)

Czechia
University Hospital Ostrava

Completed

Insertion of PICC With Intracavitary ECG Navigation

Long-term Venous Access

Czechia
University of Iceland
Medical University of Vienna; University Hospital, Basel, Switzerland; University... and other collaborators

Completed

Study of Retinal Oxygenation in Central Retinal Vein Occlusion

Retinal Vein Occlusion

Austria, Czechia, Denmark, Germany, Iceland, Switzerland, United Kingdom
Masaryk Hospital Krajská zdravotní a.s.

Completed

The Prevalence and Incidence of DVT in General ICU (preTIME)

Deep Venous Thrombosis

Czechia
Emergency Medical Service of the Central Bohemian...
Masaryk Hospital Usti nad Labem

Completed

Deep Venous Thrombosis Screening in the ICU by Nurses

Deep Venous Thrombosis

Czechia
Inotec AMD Limited

Withdrawn

Pilot Study Comparing NatroxTM Topical Oxygen Therapy to A Placebo in the Management of Non-Healing Leg Ulcers

Skin Ulcer Venous Stasis Chronic | Mixed Arteriovenous Leg Ulcer

Czechia
Theraclion

Recruiting

Extracorporeal Flow Abolition in Relation With Primary Insufficiency of Great Saphenous Veins (GSV) Using High Intensity Focused Ultrasound (HIFU) Generated by Sonovein: A Multi Center Prospective Pivotal Study (VEINRESET)

Chronic Venous Insufficiency

United States, Czechia, Austria
Arianna Anticoagulazione Foundation

Completed

WHITE Study: WHIch Decision After a First Venous ThromboEmbolism? (WHITE)

Venous Thromboembolism

Czechia
University Hospital Ostrava
Charles University, Czech Republic; University Hospital Olomouc; University of... and other collaborators

Active, not recruiting

Atherosclerotic Plaque Characteristics Associated With a Progression Rate of the Plaque in Carotids and a Risk of Stroke (ANTIQUE)

Carotid Artery Plaque

Czechia
Value Outcomes Ltd.
Alfasigma S.p.A.

Recruiting

Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower Extremities (SuloPrima)

Chronic Venous Disease | Chronic Insufficiency Venous

Czechia
Total Cardiovascular Solutions

Completed

Prevention of Radial Artery Occlusion: Prophylactic Hyperperfusion Evaluation Trial (PROPHET-II)

Occlusion of Artery

Czechia, India
University Hospital Ostrava
Ústřední fakultní vojenská nemocnice, Praha, Czechia; Vítkovická nemocnice,... and other collaborators

Completed

SONOlysis in Prevention of Brain InfaRctions During Internal Carotid Endarterectomy (SONOBIRDIE)

Internal Carotid Artery Stenosis

Czechia
B. Braun Ltd. Centre of Excellence Infection Control

Terminated

HM242-Gel vs Comparator

Venous Leg Ulcer

Czechia, Slovakia
Emergency Medical Service of the Central Bohemian...
Masaryk Hospital Usti nad Labem

Unknown

Reliability of Duplex Ultrasound for Diagnosis of Deep Vein Thrombosis Performed by Nurses

Ultrasound

Czechia
University Hospital Ostrava

Recruiting

Evaluation of Tissue Glue on PICC and Midline Catheters Insertion Sites

Adult Patients With Mid-term or Long-term Venous Access

Czechia
Allergan

Completed

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion

Macular Edema | Retinal Vein Occlusion

France, United States, Canada, Taiwan, Australia, Austria, Czechia, Portugal, Germany, Israel, Philippines, Mexico, South Africa
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion (BRIGHTER)

Branch Retinal Vein Occlusion

Greece, Hungary, Australia, Spain, United Kingdom, Italy, Netherlands, Ireland, Portugal, France, Slovakia, Canada, Switzerland, Czech Republic, Poland, Denmark, Sweden
Hoffmann-La Roche
Chugai Pharmaceutical

Completed

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion (COMINO)

Central Retinal Vein Occlusion | Macular Edema | Hemiretinal Vein Occlusion

United States, Korea, Republic of, Brazil, Japan, United Kingdom, China, Argentina, Australia, France, Hungary, Italy, Poland, Spain, Singapore, Austria, Czechia, Germany, Hong Kong, Israel, Portugal, Russian Federation, Taiwan
Hoffmann-La Roche
Chugai Pharmaceutical

Completed

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion (BALATON)

Macular Edema | Branch Retinal Vein Occlusion

United States, Korea, Republic of, Brazil, Japan, United Kingdom, China, Argentina, Australia, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Czechia, Hong Kong, Israel, Portugal, Russian Federation, Taiwan
Boehringer Ingelheim

Recruiting

A Study in Europe Based on Medical Records That Looks at the Safety of Dabigatran in Children Below 2 Years of Age Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot (DaPaR)

Venous Thromboembolism

Spain, Germany, Netherlands, Czechia, Finland, Sweden
Brno University Hospital

Terminated

High-intensity Interval Training and Telerehabilitation (HIIT-TR)

Coronary Artery Disease

Czechia
Charles University, Czech Republic

Temporarily not available

Clopidogrel Resistance and the Possibility of Its Affection

Coronary Artery Disease

Czechia
Grifols Therapeutics LLC

Completed

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Acute Peripheral Arterial Occlusion

United States, Peru, Belgium, Bulgaria, Czech Republic, Germany, India, Poland, Romania, Serbia, Slovakia, Spain
Molnlycke Health Care AB

Completed

A Multicenter, Post Marketing Clinical Follow up (PMCF) Investigation to Evaluate the Performance and Safety of a Soft Silicone Foam Dressing and to Evaluate the Performance of Standard Care in Exuding Venous Leg Ulcers

Venous Leg Ulcer (VLU)

Czech Republic
Boehringer Ingelheim

Completed

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Arthroplasty, Replacement | Prevention of Venous Thromboembolism | Moderate Renal Impairment (CrCl 30-50 mL/Min)

Austria, Canada, Czechia, Finland, Netherlands, Sweden
Na Homolce Hospital
Ministry of Health, Czech Republic

Active, not recruiting

Prediction of Atherosclerotic Plaque Progression (PPP)

Coronary Artery Disease

Czechia
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO) (COMRADE-B)

Macular Edema | Visual Impairment | Branch Retinal Vein Occlusion

Germany, United Kingdom, Hungary, Poland, Czech Republic
Bayer
Janssen Research & Development, LLC

Completed

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy (XALIA)

Venous Thrombosis | Deep Vein Thrombosis

Switzerland, France, Germany, Hungary, Spain, Sweden, Austria, Czech Republic, Italy, Moldova, Republic of, Slovenia, Ukraine, United Kingdom, Israel, Portugal, Belgium, Denmark, Greece, Netherlands, Canada, Norway
University Hospital, Motol

Unknown

Prediction of Carotid Occlusion Intolerance by Transcranial Doppler Evaluation in Patients Undergoing Carotid Artery Stenting With Proximal Flow Arrest Protection System.

Carotid Occlusion Intolerance

Czech Republic
Cook Group Incorporated

Completed

Pilot Safety Study of Injectable SIS for Critical Limb Ischemia (CLIC)

Peripheral Arterial Disease | Peripheral Vascular Disease | Critical Limb Ischemia

Czechia
University Hospital Olomouc

Recruiting

Impact of Significant Carotid Stenosis on Retinal Perfusion Measured Via Automated Retinal Oximetry

Stroke, Ischemic | Stenosis, Carotid

Czechia
Novartis Pharmaceuticals

Terminated

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion (RAVEN)

Central Retinal Vein Occlusion

China, Czechia, Germany, Russian Federation, Turkey, United States, Australia, Canada, Spain, United Kingdom, Thailand, Israel, Netherlands, Italy, Hungary, France, Greece, Puerto Rico, Malaysia, Japan
Novartis Pharmaceuticals

Terminated

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion (RAPTOR)

Branch Retinal Vein Occlusion

China, Austria, Czechia, Russian Federation, Taiwan, United Kingdom, Canada, Japan, United States, France, Israel, Germany, Italy, Hong Kong, Spain, Denmark, Slovakia, Puerto Rico, Switzerland
University Hospital, Motol
professor Josef Veselka; associate professor Petr Hájek; Martin Horváth

Completed

Long-term Follow-up NIRS-IVUS Imaging of Pre-existing Carotid Stents

Carotid Atherosclerosis | Restenosis | Carotid Artery Stenting | Near Infrared Spectroscopy | Atherosclerotic Plaque

Czechia
Sanofi

Completed

Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs (EQUINOX)

Deep Venous Thrombosis

France, Mexico, Turkey, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Denmark, Israel, Netherlands, New Zealand, Poland, Russian Federation, South Africa, Spain
Novartis Pharmaceuticals

Completed

Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRYSTAL)

Central Retinal Vein Occlusion | Macular Edema

Greece, Hungary, Turkey, Australia, Austria, Netherlands, United Kingdom, Italy, Spain, Ireland, Portugal, Slovakia, Canada, Switzerland, Czech Republic, Poland, Denmark, Sweden
National Institute of Cardiology, Warsaw, Poland

Recruiting

Drug-coated Balloon in de Novo Chronic Total Occlusions (CTO-DENOVO)

Coronary Artery Disease | Total Occlusion of Coronary Artery

Spain, France, Hungary, Czechia, Poland, Austria, Croatia, Germany, Israel, Italy, Romania
Kodiak Sciences Inc

Completed

A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO) (BEACON)

Macular Edema | Retinal Vein Occlusion

Spain, United States, Latvia, Israel, France, Italy, Hungary, Germany, Poland, Slovakia, Puerto Rico, Czechia
Kamil Novobílský

Completed

Verification of the Safety of Early Discharge in Patients After Acute ST-segment Myocardial Infarction

Coronary Artery Disease | Primary Percutaneous Coronary Intervention | Early Discharge | Acute Myocardial Infarction With ST-segment Elevation

Czechia
Institute for Clinical and Experimental Medicine
Motol University Hospital; General University Hospital in Prague

Completed

Stimulation TcPO2 Test in the PAD Diagnosis in Diabetic Foot (stimTcPO2)

Peripheral Arterial Disease

Czechia
Boehringer Ingelheim

Completed

Efficacy and Tolerability CVI (A 12-week, Double-blind, Randomised, Placebo-controlled, Multicentre Trial (CVI)

Venous Insufficiency

Germany, Austria, Czech Republic
Bayer
Regeneron Pharmaceuticals

Recruiting

A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion) (QUASAR)

Macular Edema Secondary to Retinal Vein Occlusion

Japan, Korea, Republic of, China, Israel, Lithuania, United States, Italy, Spain, Hungary, Portugal, Serbia, Poland, United Kingdom, Thailand, Czechia, Austria, Germany, Turkey, Australia, Bulgaria, Estonia, France, Georgia, Latvia, Mal... and more
Molnlycke Health Care AB

Completed

Investigation to Evaluate the Efficacy and Safety of Exufiber Versus Aquacel Extra in Moderately or Strongly Exuding Venous and Mixed Ulcers of Predominantly Venous Origin (PD-497314)

Venous Leg Ulcer

Germany, France, Czechia, Denmark, Poland, Sweden
Healthpoint

Completed

Observational Study Providing 12 Months of Safety Follow-Up From First Exposure to HP802-247

Venous Leg Ulcer (VLU)

Germany, Poland, Belgium, Hungary, Czechia
LEO Pharma

Completed

Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis

Deep Vein Thrombosis

Bulgaria, Croatia, Czechia, France, Germany, Poland, Romania, Serbia, Spain
Molnlycke Health Care AB

Active, not recruiting

A Multicentre European Study to Evaluate Granulox® Used in the Treatment Pathway of Predominantly Chronic Venous Leg Ulcers (VLUs). (Granulox01)

Venous Leg Ulcer

Croatia, Germany, United Kingdom, Hungary, Czechia, France, Poland
Healthpoint

Terminated

Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers

Ulcer | Venous Ulcer | Venous Stasis Ulcer

Germany, Poland, Belgium, Czech Republic, Hungary
Bayer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis

Venous Thromboembolism

France, Italy, Czech Republic, Canada, Netherlands, Australia, United States, Poland, South Africa, Sweden, Israel, Denmark, Brazil
Anthos Therapeutics, Inc.
Itreas

Recruiting

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE (MAGNOLIA)

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis

Austria, United States, Taiwan, Australia, China, Spain, Korea, Republic of, Italy, Hungary, France, Netherlands, Latvia, Ireland, Germany, United Kingdom, Canada, Norway, Sweden, Czechia, Switzerland
Anthos Therapeutics, Inc.
Itreas

Recruiting

A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE (ASTER)

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis

Austria, United States, Taiwan, Australia, China, Spain, Japan, Canada, Ireland, Italy, Korea, Republic of, France, Switzerland, Hungary, Netherlands, Latvia, Germany, Norway, Sweden, Czechia, United Kingdom

Clinical Trials on Venous Occlusion in Czechia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations